Lugol's Strong Iodine Solution Recalled Due to Manufacturing Quality Deviations
Ecometics, Inc. is recalling Lugol's Strong Iodine Solution nationwide due to manufacturing quality deviations. Consumers with affected prescription vials should consult their healthcare provider.
The agency’s classification
FDA (Drugs): Class II
Class II is a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences, or where the probability of serious adverse health consequences is remote.
This is the agency’s own classification, taken from its notice. The severity score below is our assessment, not the agency’s. How recall classes work
What this means for you
Our assessment, not the agency’s: severity 3/5 (High).
Real risk of harm even if no illness or injury has been reported yet. Stop using the product and follow the agency's guidance.
Our severity reasoning: FDA Class II recall involving manufacturing practice violations (CGMP deviations). No illnesses, injuries, or deaths reported. Classified as High due to the manufacturing quality defect affecting a prescription pharmaceutical, though the specific nature of the defect and potential harm are not detailed in this notice.
Plain-English summary
Ecometics, Inc. is recalling Lugol's Strong Iodine Solution USP (8mL single-use vials, prescription-only) manufactured for CooperSurgical. The product contains 0.05 grams of iodine and 0.100 grams of potassium iodide per mL (NDC 59365-6064-0).
The recall was issued because the product was not manufactured under current good manufacturing practices (CGMP), meaning the manufacturing process did not meet FDA quality standards.
Approximately 38,486 vials were distributed nationwide in the USA. The affected lots are: Lot #2E235A (expiration 2/2024) and Lot #2E293A (expiration 3/2024).
Consumers who have this product should contact their healthcare provider or pharmacist for guidance. Do not use vials from the affected lots.
The recalled product
- Product
- Lugol's (Strong Iodine Solution USP), Each mL contains Iodine 0.05gm and potassium iodide 0.100gm, 8mL Single Use Vials, Rx Only, Manufactured for CooperSurgical, Trumbull, CT 06611, NDC 59365-6064-0, Ref 6064.
- Manufacturer
- Ecometics, Inc.
- Affected units
- 38,486
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (4)
- Lot #: 2E235A
- exp: 2/2024
- 2E293A
- exp: 3/2024
Distribution
Distributed nationwide across the United States.
Part of a larger recall action
This product is one of 7 recalled by Ecometics, Inc. under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 7 products in this recall →Related recalls
Same manufacturer · Ecometics, Inc.
See all →- HighFDA Recalls AstrinGyn Surgical Hemostatic Due to Manufacturing Practice Deviations
FDA (Drugs) · 2023-08-30
- ModerateALCOLADO RELAMPAGO topical liniment recalled for manufacturing process violations
FDA (Drugs) · 2023-08-30
- ModerateBlis-To-Sol Tolnaftate Liquid Recalled for Manufacturing Practice Deviations
FDA (Drugs) · 2023-08-30
- ModerateUnguentine Ointment Recalled Due to Manufacturing Practice Deviations
FDA (Drugs) · 2023-08-30
- HighYager's Liniment Recalled for Manufacturing Practice Violations
FDA (Drugs) · 2023-08-30
Same hazard · manufacturing quality defect
See all →- HighAmantadine Hydrochloride Oral Solution Recalled Due to CGMP Deviations
FDA (Drugs) · 2023-06-07
Similar recalls
- ModerateIodine Solution Recalled for Improper Bottle Cap Seal
FDA (Devices) · 2023-12-06
- ModerateIodine Solution Recalled for Manufacturing Compliance Deviations
FDA (Drugs) · 2023-11-08
- ModerateUrsodiol USP Recall Due to Missing Stability Data and Expiration Controls
FDA (Drugs) · 2018-02-28
- ModerateFDA Recalls Cromolyn Sodium Eye Drops Nationwide for Manufacturing Defects
FDA (Drugs) · 2023-01-25
- ModerateMedline Recalls Subpotent Povidone-Iodine Scrub Solution Bottles
FDA (Drugs) · 2018-03-07
- HighLorazepam Injection Vials Recalled Due to Manufacturing Quality Control Failures
FDA (Drugs) · 2023-05-24